ENGLISH
|
财新中文
Go
Sections
Sections
Finance
World
Economy
Your Briefing
Business & Tech
Environment
Politics & Law
Society & Culture
Editorial
Opinion
Topics
China Depositary Receipts
ZTE Sanctioned
Trade Turbulence
Government Overhaul
HNA Hard Landing
Cryptocurrency
Belt and Road Initiative
Xiongan New Area
Troubled Anbang
Financial Regulatory Storm
Fintech / Internet Finance
LeEco Crisis
Selected
Weekly Digital Magazine
Doing Business in China
Tech Talk
Economic Indexes
Caixin Explains
|
CX Live
|
Podcast
|
Latest
|
Caixin View
财新中文
|
App
Di Ning
Go
Full Text
Full Text
Headline
Byline
Body Text Only
Any Time
Any Time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Sort by Newest
Sort by Newest
Sort by Relevance
News and CX Live
News and CX Live
News Stories Only
CX Live Stories Only
Chinese Biotech Firm Aims to Beat Foreign Rivals on Price With New Cancer Drug
CEO Li
Ning
told Caixin on Thursday. Merck’s Keytruda goes for about 300,000 yuan ($43,600) per
He Jiankui Used AIDS Network to Recruit 200 Couples for Gene-Editing Experiment
As the world reels from the revelation that the first gene-edited humans may have been born in China
Investigation Launched Into Baby DNA Editing Claims
ethical review committee of the institution involved. Zhang
Di
of Peking Union Medical College, who has
Baby Gene-Editing Breakthrough Claim Slammed
also banned by a Chinese regulation on reproductive technology, said Zhang
Di
, a bioethics researcher
Chinese Vaccine-Maker Fined $1.3 Billion After Scandal
Chinese rabies vaccine-maker Changchun Changsheng Life Sciences Ltd. was fined more than 9.1 billion
Officials Fall as Vaccine Scandal Widens
China’s ruling Communist Party has forced out several senior officials in connection with a widening
18 Arrested in Vaccine Scandal
Eighteen employees from a major Chinese vaccine manufacturer, including its president, have been arrested
Rabies Vaccine Producer Ordered to Halt Production
*The country’s drug watchdog said that it found evidence of data tampering at a Changchun Changsheng
China Paves Way for Faster Approval of Foreign-Made Drugs
Pharmaceutical companies will soon be able to apply for approval for some new medicines simultaneously
Merck’s HPV Vaccine Wins Lightning-Fast Approval
U.S. drugmaker Merck & Co. Inc. has received speedy approval to launch its most effective vaccine
Load more
About Caixin
|
Contact Us
|
Customer Support
|
Work with Caixin
|
Press
|
Register
|
Newsletter
|
App
|
FAQ
The Wall Street Journal
|
South China Morning Post
|
CNBC
|
MarketWatch
|
The Guardian
|
Global Times
Privacy Policy
|
Terms and Conditions
Copyright © 2017 Caixin Global Limited. All Rights Reserved.
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通